MedPath

Treatment of SÅ«â??al-Qinya (low hemoglobin level in blood) with Unani medicine Qurs-e-Zarishk

Phase 3
Conditions
Health Condition 1: D500- Iron deficiency anemia secondary to blood loss (chronic)
Registration Number
CTRI/2021/12/038795
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Hb% <12 gm/dl but > 8 gm/dl

2. Female patients in the age group of 18-65 years

3. With or without following complaints:

Fatigue

General weakness

Dizziness

Palpitation

Breathlessness

Restless leg syndrome

Thumping or whooshing sound in ear

Loss of appetite

Chest pain

Fainting

Exclusion Criteria

1. Concomitant medications or history of blood transfusion within prior to 120 days.

2. Known case of any severesystemic diseases such as allergic asthma, chronic kidney diseases, auto-immune disorders(SLE, RA, ulcerative colitis), heart diseases and canceretc.

3. Known cases of any other acute illness.

4. Known case ofhemogolobinopathy or other red celldisordersThalassemias, sickle cell anemia, congenital dyserythropoietic anemia etc.

5. History of hypersensitivity to the investigational drug or herbal drugs.

6. Pregnant and nursing women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in signs and symptoms of SÅ«â??al-Qinya (Anemia)Timepoint: 12weeks
Secondary Outcome Measures
NameTimeMethod
Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment
© Copyright 2025. All Rights Reserved by MedPath